• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

    5.910 -0.180 (-2.96%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 51,030,153
    Open 6.145
    Bid (Size) 5.980 (15)
    Ask (Size) 5.990 (3)
    Prev. Close 6.090
    Today's Range 5.705 - 6.180
    52wk Range 3.790 - 12.36
    Shares Outstanding 168,425,907
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today
    On Wednesday, major U.S. indices closed mixed, with the Nasdaq rising 1.1% to 23,043.38 and the S&P 500 slipping nearly 0.6% to 6,753.72. The Dow Jones Industrial Average was unchanged at... 
    Via Benzinga
    Topics Stocks
    What's Going On With Recursion Pharmaceuticals Stock On Wednesday?
    Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 and extended cash runway. 
    Via Benzinga

    Performance

    YTD
    -18.0%
    -18.0%
    1 Month
    +25.7%
    +25.7%
    3 Month
    +3.4%
    +3.4%
    6 Month
    +31.0%
    +31.0%
    1 Year
    -3.9%
    -3.9%

    More News

    Read More
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
    Via MarketMinute
    Topics Artificial Intelligence Derivatives
    AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
    Via MarketMinute
    Topics Artificial Intelligence
    Nvidia Has Invested in These 6 Companies. Should You Follow Suit?
    Via The Motley Fool
    Topics Artificial Intelligence
    Where Will Recursion Pharmaceuticals Be in 5 Years?
    Via The Motley Fool
    Topics Animal Testing Artificial Intelligence
    The Biotech Stock That's Too Risky for Most Investors
    Via The Motley Fool
    Topics Artificial Intelligence
    10 Hidden-Gem AI Stocks to Buy Right Now
    Via The Motley Fool
    Topics Artificial Intelligence
    Cramer's Friday Watchlist: AI Soars as Consumer Stumbles Amidst Economic Divide
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    Jim Cramer Says This Financial Stock Is A 'Total Spec,' Likes Dutch Bros,
    Via Benzinga
    Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now
    Via The Motley Fool
    Topics Artificial Intelligence
    The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape
    Via MarketMinute
    Topics Animal Testing Artificial Intelligence Intellectual Property
    Nvidia Has $4.3 Billion Invested in These 6 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch.
    Via The Motley Fool
    Topics Artificial Intelligence
    What Analysts Are Saying About Recursion Pharmaceuticals Stock
    Via Benzinga
    When You Buy Nvidia Stock, You Get a Bonus: An Artificial Intelligence (AI) ETF of Sorts
    Via The Motley Fool
    Topics Artificial Intelligence ETFs Regulatory Compliance
    3 AI Stocks Disrupting Trillion-Dollar Industries
    Via The Motley Fool
    Topics Artificial Intelligence Economy
    If You'd Invested $1,000 in Recursion Pharmaceuticals 4 Years Ago, Here's How Much You'd Have Today
    Via The Motley Fool
    Topics Artificial Intelligence
    Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn
    Via MarketMinute
    Topics Artificial Intelligence Economy Emissions
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    1 Reason to Buy This Beaten-Down Artificial Intelligence (AI) Stock, and 2 Reasons to Sell
    Via The Motley Fool
    Topics Artificial Intelligence Intellectual Property
    The Next Big Thing: 2 AI-Powered Healthcare Stocks Ready to Explode
    Via The Motley Fool
    Topics Artificial Intelligence
    Why Recursion Pharmaceuticals Stock Caught a Cold This Week
    Via The Motley Fool
    Topics Regulatory Compliance

    Frequently Asked Questions

    Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
    Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
    What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
    Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
    What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 5.910
    When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
    The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 10/09/25 04:00 PM ET
    What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 995.40M
    How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
    Recursion Pharmaceuticals, Inc. - Class A Common Stock has 995M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.